Zheng et al. have identified the upregulation of sterol regulatory element binding transcription factor 2 (SREBF2), a master regulator of cholesterol synthesis, in cisplatin-resistant ovarian cancer cells [24]. Here, SREBF2 is linked to ovarian carcinoma.